Annual FCF
-$52.42 M
-$3.06 M-6.19%
December 31, 2023
Summary
- As of February 26, 2025, JANX annual free cash flow is -$52.42 million, with the most recent change of -$3.06 million (-6.19%) on December 31, 2023.
- During the last 3 years, JANX annual FCF has fallen by -$48.06 million (-1099.93%).
- JANX annual FCF is now -1269.51% below its all-time high of -$3.83 million, reached on December 31, 2019.
Performance
JANX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$2.26 M
+$7.86 M+77.70%
September 30, 2024
Summary
- As of February 26, 2025, JANX quarterly free cash flow is -$2.26 million, with the most recent change of +$7.86 million (+77.70%) on September 30, 2024.
- Over the past year, JANX quarterly FCF has stayed the same.
- JANX quarterly FCF is now -141.70% below its all-time high of $5.41 million, reached on March 31, 2021.
Performance
JANX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$37.82 M
+$9.92 M+20.78%
September 30, 2024
Summary
- As of February 26, 2025, JANX TTM free cash flow is -$37.82 million, with the most recent change of +$9.92 million (+20.78%) on September 30, 2024.
- Over the past year, JANX TTM FCF has stayed the same.
- JANX TTM FCF is now -2072.98% below its all-time high of $1.92 million, reached on March 31, 2021.
Performance
JANX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
JANX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.2% | 0.0% | 0.0% |
| 3 y3 years | -1099.9% | 0.0% | 0.0% |
| 5 y5 years | -1269.5% | 0.0% | 0.0% |
JANX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -184.0% | at low | at high | +85.8% | -104.9% | +36.7% |
| 5 y | 5-year | -1269.5% | at low | -141.7% | +85.8% | -2073.0% | +36.7% |
| alltime | all time | -1269.5% | at low | -141.7% | +85.8% | -2073.0% | +36.7% |
Janux Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.26 M(-77.7%) | -$37.82 M(-20.8%) |
| Jun 2024 | - | -$10.12 M(-32.7%) | -$47.74 M(-10.4%) |
| Mar 2024 | - | -$15.03 M(+44.3%) | -$53.26 M(+1.6%) |
| Dec 2023 | -$52.42 M(+6.2%) | -$10.42 M(-14.5%) | -$52.42 M(-6.3%) |
| Sep 2023 | - | -$12.18 M(-22.1%) | -$55.98 M(-6.3%) |
| Jun 2023 | - | -$15.63 M(+10.1%) | -$59.73 M(+17.0%) |
| Mar 2023 | - | -$14.20 M(+1.6%) | -$51.07 M(+3.4%) |
| Dec 2022 | -$49.37 M | -$13.97 M(-12.3%) | -$49.37 M(+4.9%) |
| Sep 2022 | - | -$15.93 M(+128.6%) | -$47.05 M(+27.0%) |
| Jun 2022 | - | -$6.97 M(-44.2%) | -$37.05 M(+1.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$12.49 M(+7.2%) | -$36.36 M(+97.0%) |
| Dec 2021 | -$18.46 M(+322.5%) | -$11.65 M(+96.5%) | -$18.46 M(+118.9%) |
| Sep 2021 | - | -$5.93 M(-5.6%) | -$8.43 M(+135.2%) |
| Jun 2021 | - | -$6.28 M(-216.1%) | -$3.58 M(-287.0%) |
| Mar 2021 | - | $5.41 M(-432.1%) | $1.92 M(-143.9%) |
| Dec 2020 | -$4.37 M(+14.1%) | -$1.63 M(+50.4%) | -$4.37 M(+59.5%) |
| Sep 2020 | - | -$1.08 M(+38.7%) | -$2.74 M(+65.4%) |
| Jun 2020 | - | -$781.00 K(-10.8%) | -$1.66 M(+89.2%) |
| Mar 2020 | - | -$876.00 K | -$876.00 K |
| Dec 2019 | -$3.83 M | - | - |
FAQ
- What is Janux Therapeutics annual free cash flow?
- What is the all time high annual FCF for Janux Therapeutics?
- What is Janux Therapeutics annual FCF year-on-year change?
- What is Janux Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Janux Therapeutics?
- What is Janux Therapeutics quarterly FCF year-on-year change?
- What is Janux Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Janux Therapeutics?
- What is Janux Therapeutics TTM FCF year-on-year change?
What is Janux Therapeutics annual free cash flow?
The current annual FCF of JANX is -$52.42 M
What is the all time high annual FCF for Janux Therapeutics?
Janux Therapeutics all-time high annual free cash flow is -$3.83 M
What is Janux Therapeutics annual FCF year-on-year change?
Over the past year, JANX annual free cash flow has changed by -$3.06 M (-6.19%)
What is Janux Therapeutics quarterly free cash flow?
The current quarterly FCF of JANX is -$2.26 M
What is the all time high quarterly FCF for Janux Therapeutics?
Janux Therapeutics all-time high quarterly free cash flow is $5.41 M
What is Janux Therapeutics quarterly FCF year-on-year change?
Over the past year, JANX quarterly free cash flow has changed by $0.00 (0.00%)
What is Janux Therapeutics TTM free cash flow?
The current TTM FCF of JANX is -$37.82 M
What is the all time high TTM FCF for Janux Therapeutics?
Janux Therapeutics all-time high TTM free cash flow is $1.92 M
What is Janux Therapeutics TTM FCF year-on-year change?
Over the past year, JANX TTM free cash flow has changed by $0.00 (0.00%)